메뉴 건너뛰기




Volumn , Issue , 2015, Pages 161-163

Organ-on-a-chip for drug testing in brain diseases

Author keywords

Blood brain barrier; Drug testing; Organ on a chip

Indexed keywords

BIOMIMETICS; BLOOD;

EID: 84983315906     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: None     Document Type: Conference Paper
Times cited : (1)

References (3)
  • 1
    • 40249118217 scopus 로고    scopus 로고
    • An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening
    • Maxime. Culot, S. Lundquist, D. Vanuxeem, etc. "An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening", Toxicology in Vitro, 22, 799-811, 2008.
    • (2008) Toxicology in Vitro , vol.22 , pp. 799-811
    • Culot, M.1    Lundquist, S.2    Vanuxeem, D.3
  • 2
    • 84879317981 scopus 로고    scopus 로고
    • Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance
    • A. Patabendige, Robert A. Skinner, N.J. Abbott. "Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance", Brain Research, 1521, 1-15, 2013.
    • (2013) Brain Research , vol.1521 , pp. 1-15
    • Patabendige, A.1    Skinner, R.A.2    Abbott, N.J.3
  • 3
    • 84931479889 scopus 로고    scopus 로고
    • Activation of hypoxia signaling induces phenotypic transformation of glioma cells: Implications for bevacizumab antiangiogenic therapy
    • J.
    • H. Xu, S. Rahimpour, C.L. Nesvick, X. Zhang, J. etc., "Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy", Oncotarget, 6, 11882-93, 2015
    • (2015) Oncotarget , vol.6 , pp. 11882-11893
    • Xu, H.1    Rahimpour, S.2    Nesvick, C.L.3    Zhang, X.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.